Bioresonance in clinical fields

Content Table

The science of Bioresonance in clinical fields

Bioresonance in clinical fields -bioresonance- Bioresonance in clinical fields,History of bioresonance medicine,science of Bioresonance

From a scientific point of view, it has been proven that all body cells participate in a network of production and reception of electromagnetic signals (1). When the coordination and coherence of this electromagnetic network is disrupted (which can occur after the entry of various microorganisms), so-called pathophysiological disorder or disease occurs (2).

These pathophysiological disorders can occur for any reason (exogenous or endogenous), and the most common factors include pathogenic microorganisms (bacteria, viruses, parasites, and fungi), hormonal diseases, and allergens such as environmental and weather pollution. , types of food and drug allergens, types of toxins, heavy metals, radiation and even psychological stimuli such as stressors (3).

In the history of medicine, the 20th century is considered to be the century of entering the new field of medical science, advances in various diagnostic and therapeutic fields, finding biochemical relationships in the body and ultimately increasing life expectancy and longevity. In the same direction, complementary and alternative medicine also found an increasing development. In fact, with the progress of complementary and alternative medicine or so-called CAM, the improvement of disease symptoms, the improvement of palliative and care methods, and especially preventive medicine, were significantly developed (4).

In this regard, the science of bioresonance entered the world of medicine as a holistic scientific branch and over time it grew as a branch of personalized medicine. In fact, in using the science of bioresonance, considering the physiopathological and mental conditions of each person should be considered specifically for him (5).

It can be said that the bioresonance of “Phaistos disk” is modern, because the scientific community has not been able to clarify its etiology, nor fully clarify its disease-dissolving mechanisms. What is important is to know that in recent years, our daily life has experienced fundamental changes, it has become even more stressful and difficult, and as everything around us has changed, the way we deal with the human body must also change.

Therefore, what we expect from medicine in the 21st century is to eliminate prejudices and pave the way to accept some new approaches in our way of thinking (7,6). According to recent studies, chronic diseases have significant financial and social consequences on the global economy. Despite increasing scientific efforts to determine the cause and mechanism of chronic diseases in relation to their treatment, the number of these diseases is constantly expanding. One of the concepts that describes the etiology and mechanisms of chronic diseases is based on “epigenetic changes” (8).

Epigenetic changes are permanent changes in gene expression that are caused by changes in chromatin structure and do not involve changes in DNA sequence. The nuclear chromatin cluster has the capacity of electrical oscillation in the eukaryotic nucleus. The natural frequency of an oscillating chromatin region is determined by the physical properties of DNA-protein complexes in that region, which can be altered by its epigenetic state and associated protein factors (9).

It is possible to detect such changes using the bioresonance method, and therefore they can be used for early diagnosis of chronic diseases. Bioresonance works based on the spectral analysis of the magnetic fields of living organisms, thus allowing the therapist to distinguish between natural and unnatural frequencies emitted by the body. Electromagnetic waves as epigenetic factors can affect the dynamic changes of chromatin that lead to the activation or suppression of biochemical processes in the body and play an important role in the development or treatment of chronic diseases (10).

History of bioresonance medicine

Bioresonance in clinical fields -bioresonance- Bioresonance in clinical fields,History of bioresonance medicine,science of Bioresonance

The principle of electrotransdermal diagnostic devices was discovered by Dr. Reinhard Voll, who argued that the electrical resistance of the human body is not homogeneous and that there are meridians that appear as electric fields. There are a total of 1,000 points on the human body, corresponding to the 12 classical meridians of Chinese medicine. Dr. Voll proposed a device that could measure skin resistance at any acupuncture point in combination with galvanic skin resistance (11).

In 1922, the Russian biophysicist А.G. Gurevich discovered mitogenetic radiation. He observed that an onion root in its growing stage can increase the cell division of another root, even when the two roots are separated by glass (12). This observation was the beginning of the theory of bioresonance method through the development of the theory of biological information transmission (13). German doctor Franz Morel is considered as the “father” of bioresonance therapy.

In 1977, with extensive experience in electroacupuncture, he hypothesized that if he could use electromagnetic vibrations from the patient’s own body, his treatments could be more accurate. Thus, the first electronic device that could receive and return electromagnetic frequencies to/from the body using electrodes was developed (14). Morel introduced the treatment model using the patient’s own body signals, which was initially called MORA treatment. It was named after the initials of the inventors Morell and RAsche, an electronic engineer who designed the first therapy device.

The use of the BICOM device began in 1987 and offered many advantages over the original device. In this system, the body received the disturbed signal from the patient via input from the abdomen (as well as any part of the body). This signal was processed and amplified by the Bicom device. Then, the reverse therapeutic signal was returned to the patient through the spinal cord. The Bicom bioresonance device allowed the selection of specific parts of the total frequency spectrum for treatment (15).

This system is widely used today, and new generations of this device are also released over time. In this tool, the scanning frequency range of the device is from 1 Hz to 800 kHz and the relevant tool has a CE certificate. Interestingly, in the field of treatment, to treat all kinds of allergies, modified (reversed) electromagnetic vibrations of allergens are sent to the body, which are placed in a container connected to the bioresonance device.

In the endogenous form of bioresonance, oscillations are collected using electrodes in different parts of the body and after an electronic inversion, they are transmitted to the body for therapeutic purposes. In the exogenous form, fluctuations of bioactive substances are transferred to the human body for therapeutic purposes following electronic inversion (eg, an allergen) or amplification (eg, nosodes) (16).

 

Clinical evidence regarding bioresonance therapeutic effectiveness

Bioresonance in clinical fields -bioresonance- Bioresonance in clinical fields,History of bioresonance medicine,science of Bioresonance

In 1990, Dr. Schumacher, a pediatrician, conducted a research study at his clinic, the target population of which was 204 children with various allergies. Patients initially completed a questionnaire, and then five to nine months after bioresonance treatment, the majority (83%) reported no more allergic symptoms. Symptoms improved in 11% of respondents, and only 4.5% reported no difference in symptoms (17). In the same period, Dr. Schumacher published another study on patients with high fever (spring allergic rhinitis). In the spring after treatment, 43.4% of patients no longer had symptoms, while improvement was evident in 50.4% of patients, indicating that the effectiveness was more than 90% (18).

In 1993, Dr. Hennecke conducted a research study at his medical center. He had developed a new treatment method for allergies using the meridians of the Bicom bioresonance device. A few months after using the new method, he sent a questionnaire to his 248 patients who were being treated. This group included adults and children with atopic dermatitis, eczema, pollen allergy, as well as ocular, respiratory, and intestinal allergic conditions. Of the 200 cases analyzed, 50.4% reported no symptoms and 34.1% showed complete recovery (19).

In 2002, a study was conducted by the Russian Institute of Theoretical and Experimental Biophysics with patients with rheumatoid arthritis, which analyzed the results before and during bioresonance therapy. The state of lymphocytes of patients under medical treatment showed the activation of key antioxidant enzymes and a decrease in the content of thiol groups. In patients treated with bioresonance, the content of thiol groups was increased and glutathione peroxidase activity was completely normal. The result of the study was that bioresonance therapy activates protective mechanisms in patients with rheumatoid arthritis (20).

In recent years, similar studies have been conducted in Europe and China on children and adults evaluating the use of bioresonance in the treatment of allergies (atopic dermatitis, rhinitis, asthma, etc.) with very promising results (21).

A preliminary study of 79 patients with skin symptoms was published in March 2005. This study also showed that the treatment was effective, so that 75% of patients showed complete recovery and 22% showed improvement in their symptoms (22). Another study was conducted on 181 children with bronchial asthma or allergic rhinitis as a clinical trial (23). The patients were divided into three groups, the first group included children who were diagnosed for the first time, the second group included children for whom previous drug treatment was not successful, and the third control group included children who were diagnosed for the first time who only have received medicine.

Another study published in 2011 included 935 allergy patients who were treated using bioresonance therapy between 1998 and 2008. Three groups of symptoms were identified: patients with allergies, pain symptoms and infection. Overall evaluation of treatment effectiveness was determined as satisfactory or unsatisfactory improvement. The results for 83.3% of all treated patients were classified as very satisfactory. Specifically, among patients with allergic symptoms, 88.2% of them showed efficacy, in patients with pain symptoms the efficacy reached 85.9%, while the corresponding efficacy for infections reached 96.1%. (24).

In 2002, the results of diagnosis using EAV were compared with skin prick test in 31 patients with four allergies (moth, grass, olive pollen and nettle). The percentage of treatment response had reached 95%. During the evaluation conducted as part of this study, it was observed that “as an objective method, the Bicom device is particularly suitable for performing allergy tests” (25).

In a comprehensive study in Munich, Germany, the symptomatic treatment of a series of diseases was considered using bioresonance. Symptoms in the survey referred to various health problems such as nasal, respiratory, digestive and orthopedic problems. Based on the results of the research, it appeared that the health conditions treated with bioresonance were largely allergy-related diseases. This fact showed the effectiveness of bioresonance in the treatment of allergies and its acceptance by patients who used this method of treatment. The results show that women are more positive in choosing alternative treatments and it is also worth noting that a large percentage of men had a positive attitude towards bioresonance therapy after being recommended by their spouses.

In a 2013 survey, more women than men used CAM (67.0% vs. 50.9% for men) (28). Patients aged 2 to 76 years with a wide range of age were included in this study. The age group with the largest number of patients included people aged 31 to 45. In a study conducted in Denmark, people with MS who used CAM therapies were females aged 18–40 years (29).

This shows that in these age groups, patients are looking for new methods and new ways, apart from traditional medicine, to treat their health problems. As far as the level of education of the participants is concerned, it is evident that most of the participants had secondary and university education levels (48.23%). Patients with graduate and post-graduate education also used CAM more than patients with elementary education (63.9% vs. 53.5%) (30).
It is obvious that patients who choose alternative therapies and bioresonance are usually young and educated people who are looking for alternative treatment for their symptoms.

Furthermore, in 2002, about 62% of US adults used some form of complementary and alternative medicine (CAM) (31). It also shows a significant increase in the preference for using CAM to treat patient symptoms. A significant number of patients are choosing bioresonance as their first choice to treat their symptoms, indicating an emerging awareness for bioresonance.

Therefore, what can be said in general is that in bioresonance treatment, due to the emission of electromagnetic waves from all organic molecules and cells of the body, it is possible to record any abnormal waves and changes from all tissues and organs of the body, and therefore it is possible to track this Fluctuations and finally reaching the specific pathophysiological changes and related diseases with high precision will be possible through this branch of science.

Conclusion

Bioresonance in clinical fields -bioresonance- Bioresonance in clinical fields,History of bioresonance medicine,science of Bioresonance

Finally, it can be said that bioresonance does not intend to replace traditional medicine, but in many cases, even in cases where there are no effective drugs, it helps significantly. It is important to highlight the fact that even patients who did not show complete recovery discontinued the drug. In fact, the purpose of using the bioresonance method was and is to be considered as a complementary treatment along with the usual and effective treatment methods in order to increase the effectiveness of the treatment approach and reduce the recovery period of the treatment and finally by reducing the dose The effectiveness of the main drugs will significantly reduce the occurrence of side effects caused by these drugs.

This is an opportunity to use the data for further research in the future with the prospect of better using this method in the treatment of various human diseases. Bioresonance is a method that can help both in identifying and preventing and restoring health by identifying the underlying causes of a disease. The goal of bioresonance therapy is to restore the body’s energy flow, remove pathological conditions and increase health to restore the body’s self-healing system and treat pathological conditions that cause disease.

Bioresonance is not a panacea, it does not work miracles, and it is not supposed to replace traditional medicine and conventional treatments. However, bioresonance is very important as a new approach, which in the future can be a new diagnostic and therapeutic method to prevent and deal with hidden causes that can cause disease.

Bioresonance is a new development in the field of medicine that covers the need for early detection of disorders and disorders of the organism that can potentially turn into disease. Therefore, it should be considered as the medical science of the future and increase the knowledge of its applications as much as possible.

Summarizing the treatment response rate to bioresonance according to the involved organ based on previous studies
bioresonance in clinical fields

References of Bioresonance in clinical fields

Bioresonance in clinical fields -bioresonance- Bioresonance in clinical fields,History of bioresonance medicine,science of Bioresonance

[1]

Prasad A, Rossi C, Lamponi S, Pospíšil P, Foletti A. New perspective in cell communication: Potential role of ultra-weak photon emission. J Photochem Photobiol B 2014; 139: 47-53. [http://dx.doi.org/10.1016/j.jphotobiol.2014.03.004] [PMID: 24703 082]

[2]

Alberto F, Mario L, Sara P, Settimio G, Antonella L. Electromagnetic information delivery as a new tool in translational medicine. Int J Clin Exp Med 2014; 7(9): 2550-6. [PMID: 25356108]

[3]

Krouham AO, Martínez MC, Chiver RM. Magnetism in medicine: ONDAMED. A new diagnostic and therapeutic modality. Anales Medicos 2011; 56(2): 91-8.

[4]

Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH. Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants. Scand J Public Health 2018; 46(4): 448-55. [http://dx.doi.org/10.1177/1403494817733869] [PMID: 28975853]

[5]

Wolański L, Stanisławek A, Kachaniuk H. Knowledge of the term and methods of alternative medicine in the example of the patients of one bioresonance practice. Pol Merkuriusz Lek 2007; 23(138): 430-4. [PMID: 18432126]

[6]

Norman RL, Dunning-Davies J, Heredia-Rojas JA, Foletti A. Quantum information medicine: The future direction of medical science: Antimicrobial and other potential nontoxic treatments. World J Neurosci 2016; 6(3): 193-207. [http://dx.doi.org/10.4236/wjns.2016.63024]

[7]

Capra F. Wendezeit, Bausteine fur ein neus Weltbild. Bern: Scherz 1983.

[8]

Angrish MM, Allard P, McCullough SD, et al. Epigenetic Applications in Adverse Outcome Pathways and Environmental Risk Evaluation. Environ Health Perspect 2018; 126(4)045001 [http://dx.doi.org/10.1289/EHP2322] [PMID: 29669403]

[9]

Montagnier L, Aïssa J, Ferris S, Montagnier JL, Lavallée C. Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdiscip Sci 2009; 1(2): 81-90. [http://dx.doi.org/10.1007/s12539-009-0036-7] [PMID: 20640822]

[10]

Mehdipour P, Ed. Ebrahim i M, Sharifov S, Salili M, Chernosova L. An Introduction to Impact of Bio-Resonance Technology in Genetics and Epigenetics.Epigenetics Territory and Cancer. Dordrecht: Springer 2015.

[11]

Begher FJ. Elektroakupunktur nach Voll und Allergie ML-Verlag. Uelzen 1989.

[12]

Gurwitsch A. The mitogenetic radiation. Spinger-Verlag Berlin 1932.

[13]

Bassett CA, Bassett L. Beneficial effects of electromagnetic fields. J Cell Biochem 1993; 51(4): 387-93. [http://dx.doi.org/10.1002/jcb.2400510402] [PMID: 8496242]

[14]

Markov MS. Expanding use of pulsed electromagnetic field therapies. Electromagn Biol Med 2007; 26(3): 257-74. [http://dx.doi.org/10.1080/15368370701580806] [PMID: 17886012]

[15]

Pihtili A, Galle M, Cuhadaroglu C, et al. Evidence for the efficacy of a bioresonance method in smoking cessation: A pilot study. Forsch Komplement Med 2014; 21(4): 239-45. [http://dx.doi.org/10.1159/000365742] [PMID: 25231565]

[16]

Galle M. Bioresonance therapy with children suffering from allergies. Eur J Integr Med 2009; 1(4): 234-5. [http://dx.doi.org/10.1016/j.eujim.2009.08.023]

[17]

Schumacher P. Results of biophysical allergy therapy.Biophysical therapy of allergies. Thieme 2005; pp. 102-9.

[18]

Schumacher P. Biophysical hayfever therapy results in: Biophysical therapy of allergies. Thieme 2005; pp. 123-7.

[19]

Hennecke J. Energetic allergy therapy – possibilities and ex-periences with bicom bioresonance therapy. Med J Naturopathy 1994; 35: 427-32.

[20]

Islamov BI, Balabanova RM, Funtikov VA, Gotovskii YV, Meizerov EE. Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med 2002; 134(3): 248-50. [http://dx.doi.org/10.1023/A:1021599216581] [PMID: 12511993]

[21]

Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case-control study. J Allergy Clin Immunol 2007; 120(2): 381-7. [http://dx.doi.org/10.1016/j.jaci.2007.03.034] [PMID: 17560637]

[22]

Häfeli U. The History of Magnetism in Medicine.Magnetism in Medicine. 2nd ed. Weinheim, Germany: Wiley–VCH Verlag GmbH 2007; pp. 3-25. l

[23]

Gramowski-Voß A, Schwertle H, Pielka A, Schultz L, Steder A, Jügelt K. Enhancement of Cortical Network Activity in vitro and Promotion of GABAergic Neurogenesis by Stimulation with an Electromagnetic Field with a 150 MHz Carrier Wave Pulsed with an Alternating 10 and 16 Hz Modulation Frontiers in Neurology 2015; 14: 6-158.

[24]

Herrmana E, Galle M. Retrospective surgery study of the therapeutic effectiveness of MORA bioresonance therapy with conventional therapy resistant patients suffering from allergies, pain and infection diseases. Eur J Integr Med 2011; 3(3): 237-46. [http://dx.doi.org/10.1016/j.eujim.2011.05.051]

[25]

Giannazz E. Catania University: Diagnosi Allergologiche con Tecnologie Biofisiche, Catania Medica 9-11.2012;

[26]

Karakos P, Lialiaris T. Investigation of the effect of biosynthesis on the human body by methods of Data Analysis Data Analysis Bulletin (Greek Society of Data Analysis) (Issue 18): (under publication)

[27]

Downie SR, Andersson M, Rimmer J, et al. Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite-sensitive subjects. Allergy 2004; 59(4): 406-14. [http://dx.doi.org/10.1111/j.1398-9995.2003.00420.x] [PMID: 15005 764]

[28]

Rafferty AP, McGee HB, Miller CE, Reyes M. Prevalence of complementary and alternative medicine use: State-specific estimates from the 2001 Behavioral Risk Factor Surveillance System. Am J Public Health 2002; 92(10): 1598-600. [http://dx.doi.org/10.2105/AJPH.92.10.1598] [PMID: 12356602]

[29]

Skovgaard L, Nicolajsen PH, Pedersen E, et al. Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: A comparison of descriptive characteristics. Scand J Public Health 2013; 41(5): 492-9. [http://dx.doi.org/10.1177/1403494813481646] [PMID: 23548494]

[30]

Garland SN, Valentine D, Desai K, et al. Complementary and alternative medicine use and benefit finding among cancer patients. J Altern Complement Med 2013; 19(11): 876-81. [http://dx.doi.org/10.1089/acm.2012.0964] [PMID: 23777242]

[31]

Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343(343): 1-19. [http://dx.doi.org/10.1016/j.sigm.2004.07.003] [PMID: 15188733]